Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort
Greta Hulej, Federico Arru, Benedetta Bianchi, Alessandra Bortoluzzi, Luisa Brussino, Paola Castrignanò, Alberto Cauli, Lorenzo Cavagna, Elisabetta Chessa, Emanuele Chiara, Rossella De Angelis, Ginevra De Marchi, Roberto Depascale, Marco Di Carlo, Giacomo Emmi, Isotta Galvagni, Michela Gasparotto, M · 2026
Read Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort by Greta Hulej, Federico Arru, Benedetta Bianchi, Alessandra Bortoluzzi, Luisa Brussino, Paola Castrignanò, Alberto Cauli, Lorenzo Cavagna, Elisabetta Chessa, Emanuele Chiara, Rossella De Angelis, Ginevra De Marchi, Roberto Depascale, Marco Di Carlo, Giacomo Emmi, Isotta Galvagni, Michela Gasparotto, M (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13141197.txt.
Description
Greta Hulej and colleagues published a 2026 study of an antibody drug in lupus patients with blood problems. Lupus can lower red cells, platelets, and white cells. Those drops add danger and fatigue. The drug belimumab is used for active skin and joint disease. Italian referral centers pooled their records.
Patients were followed for up to four years. Checks ran every six months. Entry required clearly abnormal blood counts. The analysis asked whether counts recovered on treatment. Real-world cohorts include patients trials often exclude. Evidence here can guide doctors treating blood involvement. Longer follow-up strengthens confidence in any gains.
Catalog record
| CREATOR | Greta Hulej, Federico Arru, Benedetta Bianchi, Alessandra Bortoluzzi, Luisa Brussino, Paola Castrignanò, Alberto Cauli, Lorenzo Cavagna, Elisabetta Chessa, Emanuele Chiara, Rossella De Angelis, Ginevra De Marchi, Roberto Depascale, Marco Di Carlo, Giacomo Emmi, Isotta Galvagni, Michela Gasparotto, M |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |